Expression of EZH2 is associated with poor outcome in colorectal cancer

Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein family, has been demonstrated to be overexpressed in various types of human cancer, including hepatocellular carcinoma, breast, bladder and lung cancer. The mechanism of how EZH2 promotes oncogenesis has also been w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Chen, Zhuanpeng, Yang, Ping, Li, Wanglin, He, Feng, Wei, Jianchang, Zhang, Tong, Zhong, Junbin, Chen, Huacui, Cao, Jie
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778885/
https://ncbi.nlm.nih.gov/pubmed/29435024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7647
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky